Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Revenue (2018 - 2025)

Viemed Healthcare's Revenue history spans 8 years, with the latest figure at $76.2 million for Q4 2025.

  • For Q4 2025, Revenue rose 25.51% year-over-year to $76.2 million; the TTM value through Dec 2025 reached $270.3 million, up 20.52%, while the annual FY2025 figure was $270.3 million, 20.52% up from the prior year.
  • Revenue reached $76.2 million in Q4 2025 per VMD's latest filing, up from $71.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $76.2 million in Q4 2025 to a low of $27.4 million in Q2 2021.
  • Average Revenue over 5 years is $46.7 million, with a median of $46.4 million recorded in 2023.
  • Peak YoY movement for Revenue: plummeted 36.06% in 2021, then soared 38.15% in 2023.
  • A 5-year view of Revenue shows it stood at $32.0 million in 2021, then grew by 17.35% to $37.5 million in 2022, then surged by 35.28% to $50.7 million in 2023, then increased by 19.62% to $60.7 million in 2024, then rose by 25.51% to $76.2 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Revenue are $76.2 million (Q4 2025), $71.9 million (Q3 2025), and $63.1 million (Q2 2025).